103 related articles for article (PubMed ID: 19453040)
21. Prognostic significance of interaction between somatic APC mutations and 5-fluorouracil adjuvant chemotherapy in Taiwanese colorectal cancer subjects.
Chen SP; Wu CC; Lin SZ; Kang JC; Su CC; Chen YL; Lin PC; Chiu SC; Pang CY; Harn HJ
Am J Clin Oncol; 2009 Apr; 32(2):122-6. PubMed ID: 19307944
[TBL] [Abstract][Full Text] [Related]
22. Surgery for advanced colorectal cancer in elderly patients with special emphasis for radio-chemotherapy role.
Chiappa A; Bertani E; Zbar AP; Biffi R; Biella F; Bellomi M; Zampino G; Fazio N; Poldi D; Page U; Andreoni B
Hepatogastroenterology; 2007; 54(75):740-5. PubMed ID: 17591052
[TBL] [Abstract][Full Text] [Related]
23. Postoperative chemotherapy for colorectal cancer by combining 5-fluorouracil infusion and 1-hexylcarbamoyl-5-fluorouracil administration after curative resection.
Sugimachi K; Maehara Y; Ogawa M; Kakegawa T; Tomita M; Akiyoshi T
Cancer; 1996 Jan; 77(1):36-43. PubMed ID: 8630937
[TBL] [Abstract][Full Text] [Related]
24. Continuous versus intermittent infusion of prophylactic cefoxitin after colorectal surgery: a pilot study.
Suffoletta TJ; Jennings HR; Oh JJ; Stephens D; Poe KL
Pharmacotherapy; 2008 Sep; 28(9):1133-9. PubMed ID: 18752384
[TBL] [Abstract][Full Text] [Related]
25. Comparison between intravenous and oral postoperative adjuvant immunochemotherapy in patients with stage II colorectal cancer.
Ito I; Mukai M; Ninomiya H; Kishima K; Tsuchiya K; Tajima T; Oida Y; Nakamura M; Makuuchi H
Oncol Rep; 2008 Nov; 20(5):1189-94. PubMed ID: 18949420
[TBL] [Abstract][Full Text] [Related]
26. Pre-operative immunoprophylaxis with interleukin-2 may improve prognosis in radical surgery for colorectal cancer stage B-C.
Brivio F; Fumagalli L; Lissoni P; Nardone A; Nespoli L; Fattori L; Denova M; Chiarelli M; Nespoli A
Anticancer Res; 2006; 26(1B):599-603. PubMed ID: 16739327
[TBL] [Abstract][Full Text] [Related]
27. [Administration of polysaccharide K (PSK) for stage III colorectal cancer in clinical practice].
Ishibashi K; Ishiguro T; Kuwabara K; Ohsawa T; Okada N; Miyazaki T; Yokoyama M; Matsuki M; Ishida H
Gan To Kagaku Ryoho; 2008 Nov; 35(12):2283-5. PubMed ID: 19106597
[TBL] [Abstract][Full Text] [Related]
28. Etiology of delays in the initiation of adjuvant chemotherapy and their impact on outcomes for Stage II and III rectal cancer.
Cheung WY; Neville BA; Earle CC
Dis Colon Rectum; 2009 Jun; 52(6):1054-63; discussion 1064. PubMed ID: 19581846
[TBL] [Abstract][Full Text] [Related]
29. Comparison between intravenous and oral postoperative adjuvant immunochemotherapy in patients with stage III colorectal cancer.
Ito I; Mukai M; Ninomiya H; Kishima K; Tsuchiya K; Tajima T; Nakamura M; Makuuchi H
Oncol Rep; 2008 Dec; 20(6):1521-6. PubMed ID: 19020736
[TBL] [Abstract][Full Text] [Related]
30. Improved outcome of patients with colorectal cancer: the Ljubljana University Medical Centre experience.
Stor Z; Jelenc F; Juvan R; Omejc M; Bunc M; Repse S
Dig Surg; 2008; 25(2):158-63. PubMed ID: 18463413
[TBL] [Abstract][Full Text] [Related]
31. Survival and time interval from surgery to start of chemotherapy among colon cancer patients.
Zeig-Owens R; Gershman ST; Knowlton R; Jacobson JS
J Registry Manag; 2009; 36(2):30-41; quiz 61-2. PubMed ID: 19694115
[TBL] [Abstract][Full Text] [Related]
32. Hepatic arterial infusion for unresectable colorectal liver metastases combined or not with systemic chemotherapy.
Pilati P; Mammano E; Mocellin S; Tessari E; Lise M; Nitti D
Anticancer Res; 2009 Oct; 29(10):4139-44. PubMed ID: 19846962
[TBL] [Abstract][Full Text] [Related]
33. A multicenter evaluation of sequential multimodality therapy and clinical outcome for the treatment of advanced endometrial cancer.
Secord AA; Havrilesky LJ; O'Malley DM; Bae-Jump V; Fleming ND; Broadwater G; Cohn DE; Gehrig PA
Gynecol Oncol; 2009 Sep; 114(3):442-7. PubMed ID: 19560193
[TBL] [Abstract][Full Text] [Related]
34. [Effect of withdrawal of 5-fluorouracil bolus administration on recovery from neutropenia in colorectal cancer patients treated with mFOLFOX6 chemotherapy-comparison with total dosage reduction].
Ueda H; Demizu M; Oosawa M; Chihara S; Nakanishi Y; Maeda C; Yano K; Kimura F; Iwakawa S
Gan To Kagaku Ryoho; 2009 May; 36(5):789-93. PubMed ID: 19461179
[TBL] [Abstract][Full Text] [Related]
35. Modifiable risk factors in colorectal surgery: central role of surgeon's volume.
Pata G; Casella C; Nascimbeni R; Cirillo L; Salerni B
Ann Ital Chir; 2008; 79(6):427-32; discussion 432-3. PubMed ID: 19354037
[TBL] [Abstract][Full Text] [Related]
36. Adjuvant therapy with raltitrexed in patients with colorectal cancer intolerant of 5-fluorouracil: British Columbia Cancer Agency experience.
Wilson KS; Fitzgerald CA; Barnett JB; Gill S; Khoo KE
Cancer Invest; 2007 Dec; 25(8):711-4. PubMed ID: 18058467
[TBL] [Abstract][Full Text] [Related]
37. Establishment of an experimental model for continuous intraportal infusion of chemo/immunotherapeutic agents in the rat.
Rafique M; Adachi W; Shiohara E
Anticancer Res; 1995; 15(5B):1869-72. PubMed ID: 8572571
[TBL] [Abstract][Full Text] [Related]
38. [Comparative study on clinical effect of postoperative arterial infusion chemotherapy and systemic chemotherapy in gastric cancer].
Lu YF; Zeng J; Liao QH; Lin J; Huang Y; Chen JQ; Tian L; Xie NC
Zhonghua Wei Chang Wai Ke Za Zhi; 2006 Jul; 9(4):317-9. PubMed ID: 16886113
[TBL] [Abstract][Full Text] [Related]
39. Phase II study of S-1 monotherapy in paclitaxel- and cisplatin-refractory gastric cancer.
Lee SJ; Cho SH; Yoon JY; Hwang JE; Bae WK; Shim HJ; Chung IJ
Cancer Chemother Pharmacol; 2009 Dec; 65(1):159-66. PubMed ID: 19479256
[TBL] [Abstract][Full Text] [Related]
40. [Effects on micro-vessel density after pre-operative intra-arterial infusion chemotherapy in colorectal cancer].
Lin Q; Li Z; Zhang L; Zhang S; Xu G; Guo L; An D
Zhonghua Zhong Liu Za Zhi; 2002 Jan; 24(1):84-6. PubMed ID: 11977649
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
